VIB Center for Inflammation Research, Ghent, Belgium; Department of Internal Medicine, Ghent University, Ghent, Belgium; Receptor Research Laboratories, Nuclear Receptor Lab, VIB Center for Medical Biotechnology, Ghent, Belgium; Department of Biochemistry, Ghent University, Ghent, Belgium.
VIB Center for Inflammation Research, Ghent, Belgium; Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
J Allergy Clin Immunol. 2017 Nov;140(5):1364-1377.e2. doi: 10.1016/j.jaci.2016.12.970. Epub 2017 Feb 9.
Exposure to allergens, such as house dust mite (HDM), through the skin often precedes allergic inflammation in the lung. It was proposed that T2 sensitization through the skin occurs when skin barrier function is disrupted by, for example, genetic predisposition, mechanical damage, or the enzymatic activity of allergens.
We sought to study how HDM applied to unmanipulated skin leads to T2 sensitization and to study which antigen-presenting cells mediate this process.
HDM was applied epicutaneously by painting HDM on unmanipulated ear skin or under an occlusive tape. HDM challenge was through the nose. Mouse strains lacking different dendritic cell (DC) populations were used, and 1-DER T cells carrying a transgenic T-cell receptor reactive to Der p 1 allergen were used as a readout for antigen presentation. The T2-inducing capacity of sorted skin-derived DC subsets was determined by means of adoptive transfer to naive mice.
Epicutaneous HDM application led to T2 sensitization and eosinophilic airway inflammation upon intranasal HDM challenge. Skin sensitization did not require prior skin damage or enzymatic activity within HDM extract, yet was facilitated by applying the allergen under an occlusive tape. Primary proliferation of 1-DER T cells occurred only in the regional skin-draining lymph nodes. Epicutaneous sensitization was found to be driven by 2 variants of interferon regulatory factor 4-dependent dermal type 2 conventional DC subsets and not by epidermal Langerhans cells.
These findings identify skin type 2 conventional DCs as crucial players in T2 sensitization to common inhaled allergens that enter the body through the skin and can provoke features of allergic asthma.
通过皮肤接触过敏原,如屋尘螨(HDM),往往先于肺部过敏炎症。据推测,当皮肤屏障功能被破坏时,例如遗传易感性、机械损伤或过敏原的酶活性,T2 致敏会通过皮肤发生。
我们试图研究 HDM 涂抹于未经处理的皮肤如何导致 T2 致敏,并研究哪种抗原呈递细胞介导这一过程。
通过在未经处理的耳部皮肤或封闭胶带下涂抹 HDM 来进行 HDM 经皮给药。通过鼻内进行 HDM 挑战。使用缺乏不同树突状细胞(DC)群体的小鼠品系,并使用携带对 Der p 1 过敏原反应的转基因 T 细胞受体的 1-DER T 细胞作为抗原呈递的读出器。通过向幼稚小鼠进行过继转移来确定分选的皮肤衍生 DC 亚群的 T2 诱导能力。
经皮 HDM 给药导致鼻内 HDM 挑战后 T2 致敏和嗜酸性气道炎症。皮肤致敏不需要 HDM 提取物中预先存在的皮肤损伤或酶活性,但在使用过敏原进行封闭胶带下的应用时会得到促进。1-DER T 细胞的原发性增殖仅发生在区域性皮肤引流淋巴结中。经皮致敏被发现是由干扰素调节因子 4 依赖性皮肤 2 型常规 DC 亚群的 2 种变体驱动的,而不是由表皮朗格汉斯细胞驱动的。
这些发现确定了皮肤 2 型常规 DC 是常见吸入过敏原进入人体通过皮肤致敏并引发过敏哮喘特征的关键参与者。